SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Sep-24 7:09 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 13-Sep-24 | Option Exercise | 100,000 | $14.69 | $1,469,000.00 | < 1% 10.59M to 10.69M | |
11-Jun-24 6:35 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 10-Jun-24 | Option Exercise | 100,000 | $14.69 | $1,469,000.00 | < 1% 10.49M to 10.59M | |
19-Mar-24 6:55 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-24 | Payment of Exercise | 15,768 | $43.05 | $678,812.00 | (< 1%) 10.51M to 10.5M | |
19-Mar-24 6:55 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-24 | Payment of Exercise | 7,052 | $43.05 | $303,589.00 | (< 1%) 10.5M to 10.49M | |
19-Mar-24 6:55 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-24 | Payment of Exercise | 408,721 | $43.05 | $17,595,400.00 | (4%) 11.13M to 10.72M | |
19-Mar-24 6:55 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-24 | Payment of Exercise | 202,658 | $43.05 | $8,724,430.00 | (2%) 10.72M to 10.51M | |
19-Mar-24 6:55 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-24 | Option Exercise | 722,046 | $12.46 | $8,996,690.00 | 7% 10.09M to 10.81M | |
19-Mar-24 6:55 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-24 | Option Exercise | 310,930 | $12.46 | $3,874,190.00 | 3% 10.81M to 11.13M | |
08-Mar-24 4:32 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 06-Mar-24 | Payment of Exercise | 7,031 | $46.31 | $325,606.00 | (< 1%) 10.1M to 10.1M | |
08-Mar-24 4:32 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 06-Mar-24 | Payment of Exercise | 2,990 | $46.31 | $138,467.00 | (< 1%) 10.1M to 10.09M | |
06-Mar-24 10:00 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 04-Mar-24 | Grant | 64,310 | -- | -- | < 1% 10.01M to 10.08M | |
06-Mar-24 10:00 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 04-Mar-24 | Grant | 27,110 | -- | -- | < 1% 10.08M to 10.1M | |
20-Mar-23 8:02 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-23 | Payment of Exercise | 15,768 | $36.29 | $572,221.00 | (< 1%) 10.39M to 10.37M | |
20-Mar-23 8:02 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-23 | Payment of Exercise | 7,052 | $36.29 | $255,917.00 | (< 1%) 10.37M to 10.37M | |
20-Mar-23 8:02 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Mar-23 | Payment of Exercise | 25,241 | $37.60 | $949,062.00 | (< 1%) 10.54M to 10.51M | |
20-Mar-23 8:02 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Mar-23 | Payment of Exercise | 9,998 | $37.60 | $375,925.00 | (< 1%) 10.51M to 10.5M | |
20-Mar-23 8:02 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Mar-23 | Gift | 114,730 | -- | -- | (1%) 10.5M to 10.39M | |
17-Mar-23 7:01 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-23 | Payment of Exercise | 8,434 | $36.84 | $310,709.00 | (< 1%) 10.55M to 10.54M | |
17-Mar-23 7:01 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-23 | Payment of Exercise | 2,803 | $36.84 | $103,263.00 | (< 1%) 10.54M to 10.54M | |
08-Mar-23 4:05 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 06-Mar-23 | Grant | 81,383 | -- | -- | < 1% 10.44M to 10.52M | |
08-Mar-23 4:05 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 06-Mar-23 | Grant | 34,301 | -- | -- | < 1% 10.52M to 10.55M | |
23-May-22 4:05 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 20-May-22 | Private Sale (Planned) | 10,650 | $34.21 | $364,365.00 | (< 1%) 10.45M to 10.44M | |
20-May-22 4:38 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 19-May-22 | Sale (Planned) | 41,730 | $33.76 | $1,408,760.00 | (< 1%) 10.49M to 10.45M | |
20-May-22 4:38 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 18-May-22 | Private Sale (Planned) | 67,046 | $34.14 | $2,289,100.00 | (< 1%) 10.55M to 10.49M | |
18-May-22 4:06 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-May-22 | Sale (Planned) | 50,376 | $35.76 | $1,801,440.00 | (< 1%) 10.61M to 10.55M | |
18-May-22 4:06 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-May-22 | Private Sale (Planned) | 68,069 | $35.75 | $2,433,460.00 | (< 1%) 10.67M to 10.61M | |
18-Mar-22 6:54 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-22 | Payment of Exercise | 15,768 | $34.18 | $538,950.00 | (< 1%) 10.7M to 10.68M | |
18-Mar-22 6:54 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-22 | Payment of Exercise | 7,052 | $34.18 | $241,037.00 | (< 1%) 10.68M to 10.67M | |
18-Mar-22 6:54 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Mar-22 | Payment of Exercise | 25,241 | $34.22 | $863,747.00 | (< 1%) 10.73M to 10.71M | |
18-Mar-22 6:54 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Mar-22 | Payment of Exercise | 10,426 | $34.22 | $356,778.00 | (< 1%) 10.71M to 10.7M | |
17-Mar-22 5:05 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-22 | Grant | 76,914 | -- | -- | < 1% 10.64M to 10.72M | |
17-Mar-22 5:05 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-22 | Grant | 32,412 | -- | -- | < 1% 10.72M to 10.75M | |
17-Mar-22 5:05 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-22 | Payment of Exercise | 14,759 | $34.74 | $512,728.00 | (< 1%) 10.75M to 10.74M | |
17-Mar-22 5:05 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-22 | Payment of Exercise | 4,786 | $34.74 | $166,266.00 | (< 1%) 10.74M to 10.73M | |
18-Mar-21 9:11 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-21 | Grant | 127,209 | -- | -- | 1% 10.46M to 10.59M | |
18-Mar-21 9:11 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Mar-21 | Grant | 56,892 | -- | -- | < 1% 10.59M to 10.64M | |
18-Mar-21 9:11 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Mar-21 | Payment of Exercise | 25,241 | $18.44 | $465,444.00 | (< 1%) 10.49M to 10.47M | 2% |
18-Mar-21 9:11 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Mar-21 | Payment of Exercise | 8,890 | $18.44 | $163,932.00 | (< 1%) 10.47M to 10.46M | 2% |
17-Mar-21 7:38 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-21 | Payment of Exercise | 28,088 | $19.15 | $537,885.00 | (< 1%) 10.53M to 10.5M | 4% |
17-Mar-21 7:38 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 15-Mar-21 | Payment of Exercise | 9,592 | $19.15 | $183,687.00 | (< 1%) 10.5M to 10.49M | 4% |
18-Feb-21 6:58 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 18-Feb-21 | Market Sale (Planned) | 407 | $18.58 | $7,562.34 | (< 1%) 10.53M to 10.53M | (< 1%) |
18-Feb-21 6:58 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 17-Feb-21 | Market Sale (Planned) | 13,801 | $18.67 | $257,723.00 | (< 1%) 10.54M to 10.53M | (< 1%) |
18-Feb-21 6:58 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 16-Feb-21 | Market Sale (Planned) | 16,259 | $18.51 | $301,030.00 | (< 1%) 10.56M to 10.54M | (1%) |
12-Feb-21 7:11 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 12-Feb-21 | Market Sale (Planned) | 13,277 | $18.94 | $251,522.00 | (< 1%) 10.57M to 10.56M | (1%) |
12-Feb-21 7:11 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 11-Feb-21 | Market Sale (Planned) | 19,823 | $19.06 | $377,884.00 | (< 1%) 10.59M to 10.57M | (< 1%) |
12-Feb-21 7:11 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 10-Feb-21 | Market Sale (Planned) | 15,747 | $18.76 | $295,344.00 | (< 1%) 10.61M to 10.59M | (2%) |
09-Feb-21 5:30 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 09-Feb-21 | Market Sale (Planned) | 11,927 | $18.93 | $225,776.00 | (< 1%) 10.62M to 10.61M | < 1% |
09-Feb-21 5:30 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 08-Feb-21 | Market Sale (Planned) | 13,452 | $18.89 | $254,049.00 | (< 1%) 10.63M to 10.62M | < 1% |
09-Feb-21 5:30 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 05-Feb-21 | Market Sale (Planned) | 15,507 | $18.94 | $293,721.00 | (< 1%) 10.65M to 10.63M | < 1% |
05-Feb-21 8:35 PM View: | Amphastar Pharmaceuticals, ... (AMPH) | 04-Feb-21 | Market Sale (Planned) | 25,570 | $18.89 | $483,020.00 | (< 1%) 10.68M to 10.65M | (< 1%) |